Cargando…

Immunoprofiles of colorectal cancer from Lynch syndrome

Colorectal cancers associated with Lynch syndrome are characterized by defective mismatch repair, microsatellite instability, high mutation rates, and a highly immunogenic environment. These features define a subset of cancer with a favorable prognosis and high likelihood to respond to treatment wit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Walkowska, Joanna, Kallemose, Thomas, Jönsson, Göran, Jönsson, Mats, Andersen, Ove, Andersen, Mads Hald, Svane, Inge Marie, Langkilde, Anne, Nilbert, Mef, Therkildsen, Christina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6287783/ https://www.ncbi.nlm.nih.gov/pubmed/30546958 http://dx.doi.org/10.1080/2162402X.2018.1515612

Ejemplares similares

Distinct gene expression signatures in Lynch syndrome and familial colorectal cancer type X
por: Valentin, Mev Dominguez, et al.
Publicado: (2013)

Distinct Gene Expression Signatures in Lynch Syndrome and Familial Colorectal Cancer Type X
por: Dominguez-Valentin, Mev, et al.
Publicado: (2013)

Colorectal cancer in adolescents and young adults with Lynch syndrome: a Danish register-based study
por: Durhuus, Jon Ambæk, et al.
Publicado: (2021)

Molecular subtype classification of urothelial carcinoma in Lynch syndrome
por: Therkildsen, Christina, et al.
Publicado: (2018)

Frequent mismatch-repair defects link prostate cancer to Lynch syndrome
por: Dominguez-Valentin, Mev, et al.
Publicado: (2016)

Towards gene- and gender-based risk estimates in Lynch syndrome; age-specific incidences for 13 extra-colorectal cancer types
por: Therkildsen, Christina, et al.
Publicado: (2017)

Distinct gene expression profiles in ovarian cancer linked to Lynch syndrome
por: Jönsson, Jenny-Maria, et al.
Publicado: (2014)

Response to Immune Checkpoint Inhibitors Is Affected by Deregulations in the Antigen Presentation Machinery: A Systematic Review and Meta-Analysis
por: Rasmussen, Maria, et al.
Publicado: (2022)

Mismatch repair deficiency testing in Lynch syndrome-associated urothelial tumors
por: Rasmussen, Maria, et al.
Publicado: (2023)

Broadening risk profile in familial colorectal cancer type X; increased risk for five cancer types in the national Danish cohort
por: Therkildsen, Christina, et al.
Publicado: (2020)

Sense of coherence and self-concept in Lynch syndrome
por: Petersen, Helle Vendel, et al.
Publicado: (2013)

Family perspectives in lynch syndrome becoming a family at risk, patterns of communication and influence on relations
por: Bartuma, Katarina, et al.
Publicado: (2012)

Differential expression of CK20, β-catenin, and MUC2/5AC/6 in Lynch syndrome and familial colorectal cancer type X
por: Haraldsson, Stefan, et al.
Publicado: (2017)

The immune checkpoint regulator PD-L1 is a specific target for naturally occurring CD4(+) T cells
por: Munir, Shamaila, et al.
Publicado: (2013)

Editorial: Identification, risk stratification, and optimized management for Lynch Syndrome
por: Bernstein, Inge, et al.
Publicado: (2023)

Characterization of Ex Vivo Expanded Tumor Infiltrating Lymphocytes from Patients with Malignant Melanoma for Clinical Application
por: Junker, Niels, et al.
Publicado: (2011)

An Update on Immune Checkpoint Therapy for the Treatment of Lynch Syndrome
por: Therkildsen, Christina, et al.
Publicado: (2021)

Genetic anticipation in Swedish Lynch syndrome families
por: von Salomé, Jenny, et al.
Publicado: (2017)

Experiences from treatment-predictive KRAS testing; high mutation frequency in rectal cancers from females and concurrent mutations in the same tumor
por: Jönsson, Mats, et al.
Publicado: (2009)

Therapeutic Cancer Vaccines in Combination with Conventional Therapy
por: Andersen, Mads Hald, et al.
Publicado: (2010)

Characterization of T-cell responses against IκBα in cancer patients
por: Munir, Shamaila, et al.
Publicado: (2012)

Analysis of Vδ1 T cells in clinical grade melanoma-infiltrating lymphocytes
por: Donia, Marco, et al.
Publicado: (2012)

Characterization of Spontaneous Immune Responses against Long Peptides Derived from Bcl-X(L) in Cancer Patients Using Elispot
por: Larsen, Stine Kiaer, et al.
Publicado: (2012)

Long-term follow-up of anti-PD-1 naïve patients with metastatic melanoma treated with IDO/PD-L1 targeting peptide vaccine and nivolumab
por: Lorentzen, Cathrine Lund, et al.
Publicado: (2023)

Knowledge about hereditary nonpolyposis colorectal cancer; mutation carriers and physicians at equal levels
por: Domanska, Katarina, et al.
Publicado: (2009)

Identification of a cyclin B1-derived CTL epitope eliciting spontaneous responses in both cancer patients and healthy donors
por: Andersen, Rikke Sick, et al.
Publicado: (2010)

BRAF inhibition improves tumor recognition by the immune system: Potential implications for combinatorial therapies against melanoma involving adoptive T-cell transfer
por: Donia, Marco, et al.
Publicado: (2012)

T cell therapy in combination with Vemurafenib in BRAF mutated metastatic melanoma patients
por: Borch, Troels Holz, et al.
Publicado: (2014)

Focus on the Tumour Periphery in MRI Evaluation of Soft Tissue Sarcoma: Infiltrative Growth Signifies Poor Prognosis
por: Fernebro, Josefin, et al.
Publicado: (2006)

Cancer treatment: the combination of vaccination with other therapies
por: Andersen, Mads Hald, et al.
Publicado: (2008)

Durable Clinical Responses and Long-Term Follow-Up of Stage III–IV Non-Small-Cell Lung Cancer (NSCLC) Patients Treated With IDO Peptide Vaccine in a Phase I Study—A Brief Research Report
por: Kjeldsen, Julie Westerlin, et al.
Publicado: (2018)

Depletion of T lymphocytes is correlated with response to temozolomide in melanoma patients
por: Iversen, Trine Zeeberg, et al.
Publicado: (2013)

B Cells and Tertiary Lymphoid Structures: Friends or Foes in Cancer Immunotherapy?
por: Lauss, Martin, et al.
Publicado: (2022)

Molecular Subtyping of Serous Ovarian Tumors Reveals Multiple Connections to Intrinsic Breast Cancer Subtypes
por: Jönsson, Jenny-Maria, et al.
Publicado: (2014)

Prognostic Impact of Array-based Genomic Profiles in Esophageal Squamous Cell Cancer
por: Carneiro, Ana, et al.
Publicado: (2008)

Mutation spectrum in South American Lynch syndrome families
por: Dominguez-Valentin, Mev, et al.
Publicado: (2013)

Adoptive cell therapy with tumor infiltrating lymphocytes and intermediate dose IL-2 for metastatic melanoma
por: Andersen, Rikke, et al.
Publicado: (2014)

Novel Strategies for Peptide-Based Vaccines in Hematological Malignancies
por: Klausen, Uffe, et al.
Publicado: (2018)

New Pathogenic Germline Variants in Very Early Onset and Familial Colorectal Cancer Patients
por: Djursby, Malene, et al.
Publicado: (2020)

Supporter or obstructer; experiences from contact person activities among Swedish women with breast cancer
por: Carlsson, Christina, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_roq0fill8g7bb00tkiok627lsu